HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of MCI-9042, a 5-HT2 receptor antagonist, on retinal ganglion cell death and retinal ischemia.

Abstract
The neuroprotective effect of MCI-9042 (Mitsubishi Pharma Corporation) was investigated on glutamate-induced retinal ganglion cell (RGC) death in vitro and on rat retinal ischemia in vivo. RGCs were purified from retinal cells isolated from 6-day-old Wistar rats and cultured in serum-free media. After application of 25 microM glutamate, the viability of RGCs treated with or without several serotonin 2 (5-HT(2)) receptor antagonists: MCI-9042, M-1 (a major metabolite of MCI-9042), ketanserin, and LY-53857; was evaluated by calcein-acetoxymethyl ester staining. Retinal ischemia was induced by intraocular pressure (IOP) elevation (130 mmHg, 50 min). Rats were intraperitoneally injected with MCI-9042 at a dose of 3, 30 mg/kg or base at 30 min before and just after ischemia-reperfusion. Retinal damages were evaluated by histology, morphometric analysis and electroretinograms (ERGs) recordings at 7 days after ischemia-reperfusion. 25 microM glutamate decreased the number of viable RGCs to about 60 to 65% of untreated RGCs. MCI-9042, M-1, ketanserin, and LY-53857 significantly reduced glutamate-induced RGC death at concentrations of more than 100 nM, 1 nM, 1 microM and 100 nM, respectively. Ischemia-reperfusion caused thinning of the thickness between the inner plexiform layer and the outer plexiform layer and attenuation of a-and b-waves in ERG recordings. The intraperitoneal injection of MCI-9042 significantly reduced morphological and functional damages in retinal ischemia. Our data demonstrate that 5-HT(2) receptor antagonists including MCI-9042 and M-1 have the neuroprotective effects in cultured RGCs and that MCI-9042 protects against ischemic retinal diseases.
AuthorsEri Inoue-Matsuhisa, Shunji Sogo, Atsushi Mizota, Mariko Taniai, Hisashi Takenaka, Tomiya Mano
JournalExperimental eye research (Exp Eye Res) Vol. 76 Issue 4 Pg. 445-52 (Apr 2003) ISSN: 0014-4835 [Print] England
PMID12634109 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Excitatory Amino Acid Antagonists
  • Neuroprotective Agents
  • Serotonin Antagonists
  • Succinates
  • sarpogrelate
  • Glutamic Acid
Topics
  • Animals
  • Cell Death (drug effects)
  • Cells, Cultured
  • Dose-Response Relationship, Drug
  • Electroretinography
  • Excitatory Amino Acid Antagonists (pharmacology)
  • Glutamic Acid (pharmacology)
  • Neuroprotective Agents (pharmacology, therapeutic use)
  • Ocular Hypertension (complications)
  • Rats
  • Rats, Wistar
  • Reperfusion Injury (etiology, prevention & control)
  • Retinal Ganglion Cells (drug effects)
  • Retinal Vessels (drug effects)
  • Serotonin Antagonists (pharmacology, therapeutic use)
  • Succinates (pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: